Company profile
CONMED Corporation
NYSE: CNMD · Healthcare · Medical - Devices
#132 of 1,418 Healthcare companies by revenue49th-percentile growth
EA Score
83B+FH 80DQ 93GM 65SS 91
v0.1 · 65/100 weight · provisional
↑ Piotroski F, listing tenure · ↓ revenue growth (YoY), balance-sheet leverage
Methodology →Revenue TTM
$1.4B
Rev growth YoY (TTM)
+4.4%
Net income (FY)
$47.1M
Employees
3,900
as of 2026-08-10
Market cap
$1.5B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.4B$1.4B2025
Net income$47.1M$47.1M2025
Operating income$102.6M$102.6M2025
Total assets$2.3B$2.3B2025
Liabilities$1.3B$1.3B2025
Equity$1.0B$1.0B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
General Surgery58%
Orthopedic Surgery42%
By geography
UNITED STATES56%
EMEA19%
Asia Pacific15%
Americas (excluding the United States)9%
The read
What is CONMED Corporation’s revenue?
CONMED Corporation booked $1.4B in FY2025 revenue, growing 5.2% year over year — about the middle of the pack among Healthcare companies we track, at a 3.4% net margin.
Peers · Healthcare
Addus HomeCare Corporation80B+Penumbra, Inc.83B+Halozyme Therapeutics, Inc.85AHaemonetics Corporation79B+HealthEquity, Inc.82B+Phibro Animal Health Corporation76B+Neighbors
Pinellas →Key facts
CEOPatrick J. Beyer
SectorHealthcare
IndustryMedical - Devices
HeadquartersLargo, FL
ExchangeNYSE: CNMD
Employees3,900
IPO date1987-07-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.